 Home > Biochemistry News > Biotechnology News > Canadian researchers develop drugs to treat diabetic retinopathy

Canadian researchers develop drugs to treat diabetic retinopathy

 Last Update: 2021-09-06
 Source: Internet
 Author: User

Tags

genesis research

diabetic friendly alcohol

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The team led by Professor Stéphane Angers from the University of Toronto has developed a synthetic antibody that can treat diabetic retinopathy or reverse common diabetic complications, bringing new hope for the treatment of diabetic retinopathy and other eye diseases

Diabetic retinopathy is a disease that can cause blindness and affects about 30% of diabetic patients.

The research was supported by the Canadian Institutes of Health Research (CIHR) and the Ontario government and was published in EMBO Molecular Medicine

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.